Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2022
- 1Q22 Added 19,673 New Subscribers Revenues Up 12.2% YoY to RMB315.2 Million ($48.8 Million) Gross Profit Up 12.6% YoY to RMB267.3 Million ($41.4 Million) Operating Income Up 17.3% YoY to RMB156.6 Million ($24.2 Million) Non-GAAP Operating Income Up 15.5% YoY to RMB168.5 Million ($26.1 Million) Conference Call to be Held on August 31, 2021, at 8:00 a.m. ET HONG KONG, Aug. 30, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for the first quarter of fiscal 2022, ended June 30, 2021.
- 08/30/2021
|
Global Cord Blood Is An Undervalued Business With Accelerating Growth, Benefiting From China's Policy Changes
- Global Cord Blood Is An Undervalued Business With Accelerating Growth, Benefiting From China's Policy Changes
- 07/30/2021
|
Global Cord Blood Corporation Files Annual Report on Form 20-F
- HONG KONG, July 29, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual Report on Form 20-F with the U.S. Securities and Exchange Commission. The filed Form 20-F includes audited financial statements for the fiscal year ended March 31, 2021.
- 07/29/2021
|
Global Cord Blood: New China Policy Catalyst, 146% Net Cash And 24% EPS CAGR
- Global Cord Blood had a decent quarter, with subscriber growth improving both YoY and QoQ.
- 07/01/2021
|
Global Cord Blood Corporation (CO) Management on Q4 2021 Results - Earnings Call Transcript
- Global Cord Blood Corporation (CO) Management on Q4 2021 Results - Earnings Call Transcript
- 06/29/2021
|
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2021
- Added 19,367 New Subscribers in 4Q21 Revenues Up 0.8% YoY to RMB302.3 million ($46.1 million) Net Income Attributable Up 31.7% YoY to RMB127.7 million ($19.5 million) Operating Cash Flow Up 134.6% YoY to RMB211.1 million ($32.2 million) Conference Call to be Held on June 29, 2021 at 8:00 a.m. ET HONG KONG, June 28, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for the fourth quarter and full year of fiscal 2021, ended March 31, 2021.
- 06/28/2021
|
Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results
- HONG KONG, June 22, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited financial results for the fourth quarter and full year fiscal 2021 on Monday, June 28, 2021, after the U.S. market close. The Company will host a conference call at 8:00 a.m.
- 06/22/2021
|
Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal
- HONG KONG, March 15, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-binding proposal letter dated March 2, 2021 received by the Company's Board of Directors (the "Board") from Alternate Ocean Investment Company Limited ("Alternate Ocean"), pursuant to which Alternate Ocean, acting on behalf of the fund (the "Acquirer") that it manages and/or advises, proposes to acquire all of the outstanding ordinary shares of the Company for US$5.00 per ordinary share in cash, subject to certain conditions. The Board has formed a special committee of independent directors who are not affiliated with Alternate Ocean (the "Special Committee") to evaluate such proposal.
- 03/15/2021
|
Global Cord Blood Corp.: Subscriber Growth Continues With 23% EPS CAGR And 25% FCF Yield
- Global Cord Blood had a soft quarter, but subscriber growth continues unabated.
- 02/26/2021
|
Value Investment Principals' Year-End 2020 Performance And Outlook For 2021
- Value Investment Principals' Year-End 2020 Performance And Outlook For 2021
- 01/22/2021
|
Global Cord Blood Announces NHC Policy Update
- HONG KONG, Jan. 5, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today reported that China's National Health...
- 01/05/2021
|
Global Cord Blood Corp.: Solid Subscriber Growth, Net Cash Greater Than Market Cap And High FCF Yield Of 25%
- CO is a market leader with more net cash than the market cap and our price target is $6.00 [45% upside]. 1HFY2021 results saw total subscriber numbers grow by 10%, despite tough operating conditions.
- 11/25/2020
|
Global Cord Blood Corporation (CO) CEO Ting Zheng on Q2 2021 Results - Earnings Call Transcript
- Global Cord Blood Corporation (CO) CEO Ting Zheng on Q2 2021 Results - Earnings Call Transcript
- 11/25/2020
|
Global Cord Blood Corporation: An Undervalued Business But Ownership And Merger Complicate Matters
- As a business, GCBC's fundamentals impress. Net margins are ~40%, and P/E ratio is ~6.3x, plus the upfront payment/subscription model is attractive.
- 08/31/2020
|
Global Cord Blood Corporation: June Quarter YoY EPS Of 22%, Subscriber Growth, And Total 183% Net Cash
- June quarter results yielded a 22.3% gain in EPS on tighter cost-controls, subscriber growth, and fee restructuring. Net cash is 183% of the stock price.
- 08/26/2020
|
Global Cord Blood Corporation (CO) CEO Tina Zheng on Q1 2021 Results - Earnings Call Transcript
- Global Cord Blood Corporation (NYSE:CO) Q1 2021 Earnings Conference Call August 25, 2020 08:00 a.m. ET Company Representatives Tina Zheng - Chief Executive Officer, Director Albert Chen - Chief Financial Officer Cathy Bai - VP of Corporate Finance Conference Call Participants Presentation Operator Welcome everyone to Global Cord Blood Corporation’s Earnings Conference Call for the Fiscal 2021 First Quarter.
- 08/25/2020
|
Global Cord Blood Corporation to Report First Quarter Fiscal 2021 Financial Results
- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release financial results for the first quarter fiscal 2021 on Monday, August 24, 2020, after the market close.
- 08/18/2020
|
Global Cord Blood Corporation Files Its Annual Report on Form 20-F
- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual Report on Form 20-F with the U.S. Securities and Exchange Commission. The filed Form 20-F includes audited financial statements for the fiscal year ended March 31, 2020. The Form 20-F can be accessed by visiting the U.S. Securities and Exchange Commission's website at http://www.sec.gov and also be found at the Investor Relations section of GCBC's website at http://ir.globalcordbloodcorp.com.
- 07/29/2020
|
Do Hedge Funds Like Global Cord Blood Corp (CO)?
- The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […]
- 06/30/2020
|
Edited Transcript of CO earnings conference call or presentation 30-Jun-20 12:00pm GMT
- Q4 2020 Global Cord Blood Corp Earnings Call
- 06/30/2020
|
Global Cord Blood Corporation (CO) CEO Tina Zheng on Q4 2020 Results - Earnings Call Transcript
- Global Cord Blood Corporation (NYSE:CO) Q4 2020 Earnings Conference Call June 30, 2020 8:00 AM ET Company Participants Cathy Bai - VP, Corporate Finance Albert
- 06/30/2020
|
Global Cord Blood Corp. to Host Earnings Call
- NEW YORK, NY / ACCESSWIRE / June 30, 2020 / Global Cord Blood Corp. (NYSE:CO) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on June 30, 2020 at 8:00 AM ...
- 06/30/2020
|
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2020
- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for the fourth quarter and full year of fiscal year 2020 ended March 31, 2020.
- 06/29/2020
|
Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2020 Financial Results
- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release financial results for the fourth quarter and full year fiscal 2020 on Monday, June 29, 2020, after the market close.
- 06/24/2020
|
10 Penny Stocks to Buy Under $5 That Might Be Worth the Risk
- Back in September 2017, I picked seven beaten-down stocks to buy. I did so after reading a blog post from Ben Carlson, one of the best financial bloggers in the country. The problem with selecting beaten-down or penny stocks to buy is that they often come with a lot of baggage. Baggage that's not necessarily going to disappear overnight. "When dumpster diving for beaten-down shares, you must be able to understand how far divorced fundamentals have become from investor expectations," Carlson wrote in 2017. "While there were bargains galore in early 2009, late 2011 and even early 2016, if you want to find value in these markets, you have to go dumpster diving."InvestorPlace - Stock Market News, Stock Advice & Trading TipsWell, of the seven stocks on my list, only one, Kroger (NYSE:KR), is higher today than it was in September 2017. * 7 Red-Hot Vaccine Stocks Racing to Develop a Coronavirus Cure The glutton for punishment that I am, I've decided to go back to the dumpster to find 10 penny stocks to buy trading under $5 as I write this. Hopefully, I'll do a little better this time around. Penny Stocks to Buy: Banco BBVA Argentina (BBAR)Source: Shutterstock Market Cap: $765.9 million Price-to-Book: 0.62Banco Bbva Argentina (NYSE:BBAR), as its name suggests, is a financial services company based in Buenos Aires, Argentina. It has operated in Argentina since 1886. Its American Depositary Shares have been traded on the NYSE since 1993. It is the fourth-largest privately-owned bank in Argentina with 7.7% of the country's total banking system loans on a consolidated basis. At the end of 2019, it had 454 billion Argentine pesos in total assets on its balance sheet. Banco Bilbao Vizcaya Argentaria (NYSE:BBVA) is a Spanish bank. It owns 66% of the Argentinian bank. Bank of New York Mellon (NYSE:BNY) is also a large shareholder with 18% of BBVA's stock.In 2019, it made 16 billion pesos on 88 billion pesos in revenue. That revenue is up significantly from 49 billion pesos in 2017. However, investing in Argentina is not for the faint of heart. The country is notoriously bad at defaulting on its debt, making investments extremely volatile. That said, BBAR is cheaper than it has been in the past five years. I would recommend the bank stock for aggressive investors only. Global Cord Blood Corp. (CO)Source: Shutterstock Market Cap: $323.3 million Price-to-Book: 0.61After what's happened to Luckin Coffee (NYSE:LK) in 2020, most investors will probably want to steer clear of Chinese investments, except maybe Alibaba (NYSE:BABA) and a handful of other stocks. For those more adventurous, Global Cord Blood (NYSE:CO) holds three out of the seven licenses to operate cord blood banks in China. Two million babies are born each year in the three markets it operates: Beijing, Guangdong and Zhejiang. It has accumulated over 815,000 subscribers since its founding in 2003. Globally, there are 35 private cord blood banks in the U.S., another 104 in Europe and 54 in South America. Approximately four million private cord blood units are stored worldwide. Global Blood Corp. has 47% market share in China. The company charges a one-time processing fee of 9,800 Chinese Yuan and an annual storage fee of 860 Chinese Yuan for 18 years. That translates to $200 per customer per year amortized over 18 years. It adds up. * 10 Stocks to Buy to Weather the Recession In the first nine months of 2020, the company had revenues of $132.4 million, 25.4% higher than a year earlier, along with operating income of $58.8 million, 39.9% higher than in the first nine months of fiscal 2019. Silvercorp Metals (SVM)Source: Shutterstock Market Cap: $688.4 million Price-to-Book: 1.88Vancouver-based Silvercorp Metals (NYSEAMERICAN:SVM) entered the Chinese market in 2004 by acquiring the Ying project, a small producing mine in the Henan province. Today, Silvercorp produces 6.4 million ounces of silver annually, 22.7 million pounds of zinc and more than 3,500 ounces of gold.On May 17, Silvercorp announced it would acquire Guyana Goldfields (OTCMKTS:GUYFF) for 227 million CAD in a cash-and-stock deal worth $1.30 per share. Guyana operates the Aurora gold mine in Guyana. The mine produces between 145,000 and 160,000 ounces per year. It has been in production since 2016. The acquisition creates a diversified precious metals producer that generates positive free cash flow. With Guyana Goldfields under its wing, it will have a strong balance sheet to make further acquisitions and move the Aurora mine from an open-pit operation to an underground mine with more than 14 years of production capacity. Newmark Group (NMRK)Source: Shutterstock Market Cap: $737.9 million Price-to-Book: 1.16Newmark (NASDAQ:NMRK) is a full-service commercial real estate advisory that provides services to both owners and tenants. The company was spun-off from its former parent, BGC Partners (NASDAQ:BGCP), in November 2018. On May 7, Newmark reported its Q1 2020 results. On the top line, it had $483.9 million in revenue, 8.1% higher than a year earlier. On the bottom line, it had adjusted earnings of $23.5 million, 57.8% lower than in the same period a year earlier. Sales were 2% lower than the consensus estimate while its GAAP profit was 3 cents per share, 70% lower than the consensus estimate. Since it announced earnings, its shares have basically gone sideways, which is a good sign if you've owned its shares for a long time. One thing dividend investors will notice is that the company cut its quarterly dividend by 90% from 10 cents to 1 cent starting with the June payment. With the dividend cut, it currently yields slightly less than 1%. * 7 Gun Stocks to Buy During the Coronavirus Pandemic Expect Newmark to face a tough commercial real estate market over the next few quarters. However, it has made several moves, including the dividend cut, to ensure it remains financially sound during the economic downturn caused by the novel coronavirus. Smith Micro Software (SMSI)Source: Shutterstock Market Cap: $173.6 million Price-to-Book: 3.28Smith Micro Software (NASDAQ:SMSI) provides software to wireless carriers to enhance their user experience. It currently has three main products: SafePath, CommSuite and ViewSpot. In the latest quarter ended March 31, SafePath generated 59% of the company's $13.2 million in wireless revenue during the quarter while CommSuite accounted for another 34%.SafePath's solutions keep families' devices connected providing a safer, more enjoyable digital experience. CommSuite provides voice-to-text voice mail messaging for mobile devices that can be accessed from anywhere using any device. It has been installed on more than 18 million mobile devices. In the first quarter, Smith Micro had adjusted net income of $4.1 million, up significantly from $776,000 a year earlier. The company continues to expand its product offerings beyond SafePath and CommSuite, providing investors with a diversified penny stock opportunity. One thing to be aware of before you invest: Sprint accounts for 88% of the company's total revenue. Its merger with T-Mobile (NASDAQ:TMUS) could affect the relationship in the future. Orion Energy Systems (OESX)Source: Shutterstock Market Cap: $138.3 million Price-to-Book: 4.40Orion Energy Systems (NASDAQ:OESX) manufactures indoor and outdoor LED lighting and lighting solutions for all kinds of different industries, including agriculture, healthcare, retail, etc. The company's lighting solutions are 100% turnkey, providing customers with just one touchpoint when it comes to service.Its customers are some of the biggest names including Costco (NASDAQ:COST), Coca-Cola (NYSE:KO) and General Electric (NYSE:GE).On March 16, Orion was added to the CIBC Atlas Clean Energy Index, an index with exposure to U.S. and Canadian companies operating in the clean energy sector. Segments include solar, wind, hydro, geothermal, electric vehicles, LED and many others. As of May 26, the index had a one-year return of 29.9%. In February, Orion reported Q3 2020 results that included revenue growth of 110%. More importantly, its net income went from a loss of $700,000 in Q3 2019 to a profit of $2.3 million. As a result of its strong showing in the third quarter, it upped its fiscal 2020 guidance from $140 million at the midpoint to $152.5 million at the midpoint. * 6 Companies to Invest in Today for 10 Years of Growth Orion is definitely an under-the-radar type of penny stock opportunity. Mistras Group (MG)Source: Shutterstock Market Cap: $127.9 million Price-to-Book: 0.75Mistras Group (NYSE:MG) proclaims it is the only publicly traded pure-play asset protection company in the U.S. with more than 115 locations worldwide managed by approximately 5,000 employees.Founded in 1978, the company originally known as Physical Acoustics Corporation, became Mistras Group in 2007. Two years later it completed its IPO. The company helps industries such as oil and gas keep their assets running safely. Oil and gas account for approximately 56% of its revenue with aerospace and defense (15%) and industrials (12%) helping carry some of the load. Mistras' core business involves the non-destructive testing (NDT) of assets, a market that's estimated to be $14 billion worldwide. It has an approximately 4.5% share of the global NDT market.In the near term, Covid-19 is causing delays in projects, especially in the oil and gas sector. As a result, it expects revenues to face declines in the second quarter, but that higher oil prices means the third and fourth quarters will likely see energy companies undertake testing projects they've postponed due to the pandemic and lower prices.Down almost 70% year to date, Mistras is worth taking a closer look at. Office Depot (ODP)Source: Jonathan Weiss / Shutterstock.com Market Cap: $1.3 billion Price-to-Book: 0.
- 05/29/2020
|
Stocks That Hit 52-Week Lows On Thursday
|
Stocks That Hit 52-Week Lows On Monday
|
Legendary Drummer And Afrobeat Co-founder Tony Allen Dies
- Legendary drummer and afrobeat co-founder Tony Allen dies
- 05/01/2020
|
Global Cord Blood provides further update on COVID-19
- Global Cord Blood (NYSE:CO) estimates new subscriber number in fiscal 2021 will decrease to 60K-65K, a 19%-29% Y/Y decrease.During this difficult time, the Company has prioritized employee safety and
- 04/27/2020
|
BRIEF-Global Cord Blood Corporation Provides Update on COVID-19
- Global Cord Blood Corp:
- 04/27/2020
|
Global Cord Blood Expects New Subscriber Number In 2021 To Decrease To 60K-65K, Down From FY20 Target Of 80K-85K
|
Global Cord Blood Corporation Provides Further Update on COVID-19
- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today provided an update on the impact of the 2019 novel coronavirus ("COVID-19") on the Company's expected fiscal 2021 operations.
- 04/27/2020
|
Global Cord Blood Corporation Provides Further Update on COVID-–9
|
Casino Reports Strong Q1 Sales on COVID-19-Induced Stockpiling and Food at Home Consumption
|
Those Who Purchased Herc Holdings (NYSE:HRI) Shares Three Years Ago Have A 56% Loss To Show For It
- Herc Holdings Inc. (NYSE:HRI) shareholders will doubtless be very grateful to see the share price up 55% in the last...
- 04/22/2020
|
Financial Contrast: Global Cord Blood (NYSE:CO) and Crescent Capital BDC (NYSE:CCAP)
- Global Cord Blood (NYSE:CO) and Crescent Capital BDC (NASDAQ:CCAP) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk. Analyst Ratings This is a breakdown of current recommendations and price targets for […]
- 04/19/2020
|
Edited Transcript of CO earnings conference call or presentation 12-Mar-20 12:00pm GMT
- Q3 2020 Global Cord Blood Corp Earnings Call
- 04/08/2020
|
The Daily Biotech Pulse: Sanofi, Regeneron Finalize Praluent Restructuring, Natus Pre-Announces Q1 Shortfall, Alcon To Delay Dividend Initiation
- Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 6.) * Forty Seven Inc (NASDAQ: FTSV) * Masimo Corporation (NASDAQ: MASI) * Seattle Genetics, Inc. (NASDAQ: SGEN) * Vertex Pharmaceuticals Incorporated
- 04/07/2020
|
Harmony Painting Offers Popcorn Ceiling Removal in Denver
- DENVER, CO / ACCESSWIRE / April 5, 2020 / Harmony Painting | Denver Interior, Exterior, and Commercial Painters has announced that they offer popcorn ceiling removal for homes and buildings in Denver, Colorado and neighboring areas. The popcorn ceiling or textured ceiling or stucco ceiling was popular
- 04/06/2020
|
Analyzing Opes Acquisition (NASDAQ:OPES) and Global Cord Blood (NASDAQ:CO)
- Global Cord Blood (NYSE:CO) and Opes Acquisition (NASDAQ:OPES) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership. Institutional & Insider Ownership 15.9% of Global Cord Blood shares are held by institutional […]
- 04/04/2020
|
Global Cord Blood (NYSE:CO) Downgraded by ValuEngine
- Global Cord Blood (NYSE:CO) was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating in a report released on Thursday, ValuEngine reports. Global Cord Blood stock opened at $2.96 on Thursday. Global Cord Blood has a one year low of $2.88 and a one year high of $7.69. The business has […]
- 04/02/2020
|
Rising Trends of Kombucha Market in Worldwide: Topmost Key Players like KeVita. ...
|
Edited Transcript of CO earnings conference call or presentation 12-Mar-20 12:00pm GMT
- Q3 2020 Global Cord Blood Corp Earnings Call
- 03/31/2020
|
Andina Acquisition Corp. III (NASDAQ:AMCI) and Global Cord Blood (NASDAQ:CO) Head to Head Analysis
- Andina Acquisition Corp. III (NASDAQ:AMCI) and Global Cord Blood (NYSE:CO) are both small-cap unclassified companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings. Profitability This table compares Andina Acquisition Corp. III and Global Cord Blood’s […]
- 03/30/2020
|
Global Smart Speaker Market Poised To Garner Maximum Revenues With Prominent Players Like ...
|
Rigid Polyurethane Foams Market [Review: —…—…-—…—9] | Top Players – BASF SE, ...
|
Critical Survey: Global Cord Blood (NYSE:CO) and Crescent Capital BDC (NYSE:CCAP)
- Global Cord Blood (NYSE:CO) and Crescent Capital BDC (NASDAQ:CCAP) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, institutional ownership and profitability. Profitability This table compares Global Cord Blood and Crescent Capital BDC’s net margins, […]
- 03/28/2020
|
Short Interest in Global Cord Blood Corp (NYSE:CO) Rises By 333.1%
- Global Cord Blood Corp (NYSE:CO) saw a large growth in short interest during the month of March. As of March 13th, there was short interest totalling 62,800 shares, a growth of 333.1% from the February 27th total of 14,500 shares. Based on an average trading volume of 75,900 shares, the days-to-cover ratio is currently 0.8 […]
- 03/28/2020
|
Automotive Battery Thermal Management System Market [Review: —…—…-—…—9] | Top ...
|
Opes Acquisition (NASDAQ:OPES) vs. Global Cord Blood (NASDAQ:CO) Critical Analysis
- Opes Acquisition (NASDAQ:OPES) and Global Cord Blood (NYSE:CO) are both small-cap unclassified companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability and analyst recommendations. Valuation & Earnings This table compares Opes Acquisition and Global Cord Blood’s gross revenue, […]
- 03/27/2020
|
55 Stocks Moving In Friday's Mid-Day Session
|
Coronavirus Insurance: Aetna Waives Cost Sharing, Co-Pays For COVID-19 Hospital Stays
- The company also is waiving authorization requests to expedite admissions.
- 03/25/2020
|
The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps Down
- Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 24) * BELLUS Health Inc (NASDAQ: BLU) * Global Cord Blood Corp (NYSE: CO) * Thermogenesis Holdings Inc (NASDAQ: THMO)(reacted to its fourth-quarter
- 03/25/2020
|
3 Medical Companies With the Strength to Weather Coronavirus Fears
- Stocks to consider as stimulus bill fails and CVS accelerates labor demand Continue reading...
- 03/23/2020
|
3 Medical Companies With the Strength to Weather Coronavirus Fears
- 3 Medical Companies With the Strength to Weather Coronavirus Fears, Stocks: CVS,BIO,BIO.B,CO,FONR, release date:Mar 23, 2020
- 03/23/2020
|
Stocks That Hit 52-Week Lows On Monday
- On Monday morning, 720 companies hit new 52-week lows.
Noteworthy Mentions:
The largest company by market cap to set a new 52-week low was Alphabet (NASDAQ: GOOGL)...
- 03/23/2020
|
' Medical Companies With the Strength to Weather Coronavirus Fears
|
76+ Women-Owned Small Businesses To Support From A Distance
- Shop these women-owned small business from afar. They could use a boost right about now.
- 03/22/2020
|
Leisure Acquisition (NASDAQ:GPAQ) & Global Cord Blood (NASDAQ:CO) Head to Head Contrast
- Leisure Acquisition (NASDAQ:GPAQ) and Global Cord Blood (NYSE:CO) are both small-cap unclassified companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability. Profitability This table compares Leisure Acquisition and Global Cord Blood’s net margins, return on […]
- 03/22/2020
|
HPMC Capsules Market —…–9 New Opportunities, Top Trends, Rising Demand, Emerging Growth, ...
|
Nioh 2 Guide: Tips to Help You Survive the Game Longer; Plus Learn How to Play Co-Op!
- Plus, learn how to play co-op!
- 03/14/2020
|
Microsoft Co-founder Bill Gates Leaves Board
- Microsoft co-founder Bill Gates leaves board
- 03/14/2020
|
Cell Culture Media Market —…–9-—…—7 / Size, Share, Revenue Growth, Development and ...
|
Global Cord Blood Corporation (CO) Q3 2020 Earnings Call Transcript
- CO earnings call for the period ending December 31, 2019.
- 03/12/2020
|
Sad News for Grand Theft Auto IV Fans as GTA Co-Creator Leaves Rockstar Games: Could GTA 6 Happen without Him?
- Rockstar Games will be experiencing the departure of Dan Houser from their company, and as this happens, Grand Theft Auto IV fans are uneasy regarding the issue about whether or not there will be a new GTA 6.
- 03/12/2020
|
BRIEF-Global Cord Blood Says Quarterly Revenue Rose 31.7%
- Global Cord Blood Corp:
- 03/11/2020
|
Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2020
- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for the third quarter and first nine months of fiscal year 2020 ended December 31, 2019.
- 03/11/2020
|
Afternoon Market Stats In 5 Minutes
- Movers Indices • S&P 500 ETF (NYSE:SPY) fell 5.48% to $272.60.• Nasdaq ETF (NASDAQ:QQQ) decreased 4.90% to $194.10.• Dow Jones Industrial Average ETF (NYSE:DIA) fell 6.09% to $235.11.• FTSE/Xinhua China 25 ETF (NYSE:FXI) decreased 3.34% to $38.82.• FTSE Europe ETF (NYSE:VGK) fell 6.13% to $46.13.Commodities
- 03/11/2020
|
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
- Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Aytu Bioscience Inc (NASDAQ: AYTU ) ( announced a deal to distribute COVID-19 test) Centogene NV (NASDAQ: CNTG ) Forty Seven Inc (NASDAQ: FTSV ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 10) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Akari Therapeutics PLC (NASDAQ: AKTX ) Akcea Therapeutics Inc (NASDAQ: AKCA ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Alkermes Plc (NASDAQ: ALKS ) Allena Pharmaceuticals Inc (NASDAQ: ALNA ) ANCHIANO THERAP/S ADR (NASDAQ: ANCN ) AngioDynamics, Inc. (NASDAQ: ANGO ) ANI Pharmaceuticals Inc (NASDAQ: ANIP ) Anixa Biosciences Inc (NASDAQ: ANIX ) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC ) Aptevo Therapeutics Inc (NASDAQ: APVO ) Aptinyx Inc (NASDAQ: APTX ) Assertio Therapeutics Inc (NASDAQ: ASRT ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Atossa Therapeutics Inc (NASDAQ: ATOS ) Autolus Therapeutics Ltd – ADR (NASDAQ: AUTL ) AxoGen, Inc Common Stock (NASDAQ: AXGN ) Axovant Gene Therapies Ltd (NASDAQ: AXGT ) Bausch Health Companies Inc (NYSE: BHC ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM ) BENITEC BIOPHAR/S ADR (NASDAQ: BNTC ) BioLife Solutions Inc (NASDAQ: BLFS ) bluebird bio Inc (NASDAQ: BLUE ) Black Diamond Therapeutics Inc (NASDAQ: BDTX ) Capricor Therapeutics Inc (NASDAQ: CAPR ) Celcuity Inc (NASDAQ: CELC ) Cerecor Inc (NASDAQ: CERC ) Chembio Diagnostics Inc (NASDAQ: CEMI ) Eiger Biopharmaceuticals Inc (NASDAQ: EIGR ) Enochian Biosciences Inc (NASDAQ: ENOB ) Entasis Therapeutics Holdings Inc (NASDAQ: ETTX ) Eton Pharmaceuticals Inc (NASDAQ: ETON ) Evolus Inc (NASDAQ: EOLS ) Exicure Inc (NASDAQ: XCUR ) Eyepoint Pharmaceuticals Inc (NASDAQ: EYPT ) Five Prime Therapeutics Inc (NASDAQ: FPRX ) Gossamer Bio Inc (NASDAQ: GOSS ) Gritstone Oncology Inc (NASDAQ: GRTS ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Heron Therapeutics Inc (NASDAQ: HRTX ) Incyte Corporation (NASDAQ: INCY ) INmune Bio Inc (NASDAQ: INMB ) Integra Lifesciences Holdings Corp (NASDAQ: IART ) Invivo Therapeutics Holdings Corp (NASDAQ: NVIV ) Jaguar Health Inc (NASDAQ: JAGX ) Jazz Pharmaceuticals PLC (NASDAQ: JAZZ ) Kura Oncology Inc (NASDAQ: KURA ) Lantheus Holdings Inc (NASDAQ: LNTH ) TapImmune Inc.
- 03/11/2020
|
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2020 Financial Results
- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited financial results for the third quarter and first nine months of fiscal year 2020 on Wednesday, March 11, 2020, after the market close.
- 03/09/2020
|
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal —…—… ...
|
Critical Survey: Diamond Eagle Acquisition (NYSE:VRT) & Global Cord Blood (NYSE:CO)
- Diamond Eagle Acquisition (NYSE:VRT) and Global Cord Blood (NYSE:CO) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and profitability. Institutional & Insider Ownership 61.3% of Diamond Eagle Acquisition shares are […]
- 03/07/2020
|
Muller Technology Launches Versatile Automation System for Injection Molded Packaging
- Muller Technology Colorado (formerly CBW Automation), a supplier of robots and automation systems for thin-wall packaging based in Fort Collins, CO, announced the launch of the M-Line robot. The integrated robotic and automation system delivers significantly greater flexibility and versatility for the production of injection molded packaging, according to the company. The M-Line automation system is designed to boost machine flexibility and versatility to help processors adapt to shorter-term business contracts. Image courtesy Muller Technology Colorado. The M-Line accommodates various mold types and pitches, and single to 48-cavity molds. Most current automation systems are restricted to certain molds and specified cavitation. Processors are adapting to shorter-term business contracts, which can negatively affect overall machine utilization, according to Muller. The M-Line enables processors to more easily accommodate market fluctuations and changing production volumes, and achieve higher machine utilization rates. “Our newly designed M-Line provides an unprecedented level of flexibility and versatility that significantly raises machine output and efficiency,” said John Taggert, Vice President of engineering for Muller Technology Colorado.
- 03/04/2020
|
Vodafone Idea soars 12% as co pays Rs 3,000 crore towards spectrum dues
- Vodafone Idea has yet to pay the telecom department AGR dues of around Rs 53,000 crore.
- 03/03/2020
|
Global Pipettes and Accessories Market Research Report (—…–9-—…—4) by Future Trend, ...
|
Athos Capital Ltd Acquires 24,850 Shares of Global Cord Blood Corp (NYSE:CO)
- Athos Capital Ltd raised its holdings in shares of Global Cord Blood Corp (NYSE:CO) by 71.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 59,862 shares of the medical research company’s stock after purchasing an additional 24,850 shares during the quarter. Athos […]
- 02/29/2020
|
Automotive Body Sealing System Market (New PDF) [Review: —…—…-—…—9] | Top Players ...
|
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
- Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 27) Global Cord Blood Corp (NYSE: CO ) Cleveland BioLabs, ...
- 02/28/2020
|
Stocks That Hit 52-Week Lows On Friday
|
Stocks That Hit 52-Week Lows On Thursday
|
Global Sugar Candy Market —…—… | Share, Size, Regional Trend, Future Growth, Leading ...
|
$70 million funding may take Khatabook valuation to $300 million
- In January, the firm co-led a $105 million round in mobility startup Bounce, while also participating in B2B packaging materials marketplace Bizongos $30 million Series C funding round.
- 02/24/2020
|
USFDA reopens investigation of Aurobindo’s unit 4 facility
- Co receives USFDA communique that inspection completed by the regulator in Nov 2019 is still open.
- 02/22/2020
|
Contrasting Global Cord Blood (NYSE:CO) and FORUM MERGER II/SH CL A (NYSE:FMCI)
- FORUM MERGER II/SH CL A (NASDAQ:FMCI) and Global Cord Blood (NYSE:CO) are both small-cap unclassified companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, earnings and profitability. Profitability This table compares FORUM MERGER II/SH CL A and Global […]
- 02/21/2020
|
Devil May Cry 3 Finally Hits the Switch! New Co-op Mode and How to Use it
- Devil May Cry has been dormant for quite some time, but fans of this franchise are getting a shocking revelation!
- 02/21/2020
|
Global Sausage Casings Market —…—…: Industry Overview, Shares, Growing Demand, Market ...
|
Disney and Fox's Merger Resulted in the Co-op Alien Game to be Cancelled
- Disney and Fox's Merger has a silver lining: Good news for Avengers fans, but it means cancelation of upcoming co-op Alien game.
- 02/19/2020
|
Boring Co. News: Breakthrough Announced On First Las Vegas Loop Tunnel
- The Boring Co. began excavating the tunnel three months ago.
- 02/14/2020
|
Coronavirus update: 1,383 deaths, more than 63,000 sickened, Expedia predicts impact beyond Q1
- There are more than 63,000 cases of COVID-19, the novel coronavirus that was first identified in December in Wuhan, China, and 1,383 deaths, according to the World Health Organization.
- 02/14/2020
|
Global Cord Blood's stock rises as it predicts coronavirus impact
- Shares of Global Cord Blood Corp. were up 0.2% in premarket trading on Friday after the Hong Kong-based company said it expects a negative impact to its fourth-quarter performance due to COVID-19, the new coronavirus that has sickened at least 48,000 people, primarily in China. Global Cord Blood, which is an umbilical cord blood banking operator, attribution the projected impact to a combination of factors: some of its workers are not able to return to work due to travel restrictions; hospitals are restricting access to sales representatives, including those employed by Global Cord Blood; and the company's operating costs may rise because it has had to purchase additional medical supplies and equipment for its employees and clients. Global Cord Blood said in a news release that it may adjust its sales target for fiscal 2010 and its "strategy" for fiscal 2021. The company's stock is down 27% over the past year, while the S&P; 500 has gained 22%.
- 02/14/2020
|
BRIEF-Global Cord Blood Corp Provides Update On Impact Of Coronavirus
- Global Cord Blood Corp:
- 02/14/2020
|
Global Cord Blood Corporation Provides Update on Impact of Coronavirus
- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today provided an update on the impact of the 2019 novel coronavirus ("2019-nCoV") on its operations.
- 02/14/2020
|
UPDATE: Global Cord Blood Reports 'has increased its efforts to purchase necessary medical supplies and equipment, which is expected to lead to an increase in operating costs'
|
IRCTC jumps 12.5% on strong Q3 nos; Co announces interim dividend of Rs 10
- Read more about IRCTC jumps 12.5% on strong Q3 nos; Co announces interim dividend of Rs 10 on Business Standard. For the quarter under review, IRCTC posted a whopping 178 per cent year-on-year (YoY) jump in its net profit at Rs 206 crore
- 02/13/2020
|
Athos Capital Ltd Buys Alibaba Group Holding, Tech Data Corp, The Medicines Co, Sells Celgene ...
|
Global Cord Blood (NYSE:CO) and GS ACQUISITION /SH CL A (NYSE:GSAH) Financial Analysis
- Global Cord Blood (NYSE:CO) and GS ACQUISITION /SH CL A (NYSE:GSAH) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, valuation, risk, analyst recommendations and dividends. Risk & Volatility Global Cord Blood has a beta of 0.17, […]
- 02/07/2020
|
Global Cord Blood Corporation Appoints Mr. Siu Chuen Cheng as Independent Non-executive Director
- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced the appointment of Mr. Siu Chuen Cheng as a new independent non-executive director to the Board of Directors of the Company (the "Board").
- 02/06/2020
|
Avenue Supermarts shares hit fresh record high as co looks to raise Rs 4,000 crore though QIP
- The company is selling 2 crore shares at a floor price of Rs 1,999.04.
- 02/06/2020
|
ITI shares rally 9% as co withdraws Rs 1,400 crore FPO
- The FPO, which opened on January 24, was initially scheduled to close on January 28.
- 02/06/2020
|
Global Cord Blood Corporation Appoints Mr. Siu Chuen Cheng as Independent Non-executive Director
|
Is Co-founder of Rockstar Games Dan Houser to Leaving the Studio For Good?
- One of the co-founders of Rockstar Games, Dan Houser, will be leaving the studio by March 11, 2020. He had been on leave from the studio starting Spring 2019 for undisclosed reasons.
- 02/05/2020
|
Walt Disney Co. Results Lifted By 'Star Wars,' 'Frozen'
- Walt Disney Co. results lifted by 'Star Wars,' 'Frozen'
- 02/05/2020
|
Walt Disney Co. Results Lifted By 'Star Wars,' 'Frozen'
- Walt Disney Co. results lifted by 'Star Wars,' 'Frozen'
- 02/04/2020
|
Casino Guichard Perrachon : Une nouvelle année record pour Banque Casino qui confirme son statut de leader français des facilités de paiement digitales | Zone bourse
- Information presse Le 03 février 2020 Une nouvelle année record pour Banque Casino qui confirme son… | 3 février 2020
- 02/03/2020
|
Automotive Sun Visor Market (PDF) [Review: —…—…-—…—9] | Top Players – Irvin ...
|
Raspberry (Rubus Idaeus) Seed Oil Market (PDF) Review —…—…-—…—9 | Top Players – ...
|
Innovation from the phone box to watch in 2020
- In conversation with Hugo Feiler, co founder and CEO https://minima.global/ with some interesing innovation insights. Do you remember the public phone box? Beloved of Dr Who and his Tardis, the humble phone box is fast disappearing from our typography as mobile devices remove the need for public phones. In some places, local communities have converted these […]
- 01/27/2020
|
Financial Review: GS ACQUISITION /SH CL A (NYSE:GSAH) and Global Cord Blood (NYSE:CO)
- GS ACQUISITION /SH CL A (NYSE:GSAH) and Global Cord Blood (NYSE:CO) are both small-cap unclassified companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends and profitability. Insider and Institutional Ownership 44.0% of GS ACQUISITION /SH CL A […]
- 01/27/2020
|
Coffee Day hits 5% upper circuit limit as co sells Way2Wealth Securities
- The transaction may fetch Coffee Day Enterprises about Rs 30 crore, people briefed on the matter said.
- 01/24/2020
|
Casino Guichard Perrachon : Bilan semestriel du contrat de liquidité de la société Casino, Guichard-Perrachon | Zone bourse
- CASINO, GUICHARD-PERRACHON Société anonyme au capital de 165 892 131,90 € Siège social : 1, Cours Antoine… | 21 janvier 2020
- 01/21/2020
|
Piramal Enterprises shares climb 5.5 pc as co sells DRG business
- Shares of Piramal Enterprises on Friday climbed 5.5 per cent after the company said it has signed an agreement for the sale of its Decision Resources Group DRG
- 01/17/2020
|
CASINO GUICHARD : Pénalisé par les grèves, Casino connaît un brutal retour à la réalité en Bourse
- https://www.tradingsat.com/casino-guichard-FR0000125585/actualites/casino-guichard-penalise-par-les-greves-casino-connait-un-brutal-retour-a-la-realite-en-bourse-896101.html
- 01/17/2020
|
Casino Guichard Perrachon : Pénalisé par les grèves, Casino abaisse son objectif de ROC pour 2019 | Zone bourse
- Le groupe de grande distribution Casino a abaissé jeudi son objectif de résultat opérationnel courant pour l'année 2019, en raison de l'impact des grèves sur ses enseignes françaises au mois de… | 16 janvier 2020
- 01/16/2020
|
CASINO GUICHARD : Quand l'arrière-petit-fils du fondateur de Casino réclame la tête de Naouri
- https://www.tradingsat.com/casino-guichard-FR0000125585/actualites/casino-guichard-quand-l-arriere-petit-fils-du-fondateur-de-casino-reclame-la-tete-de-naouri-895939.html
- 01/16/2020
|
Head-To-Head Comparison: GS ACQUISITION /SH CL A (NYSE:GSAH) vs. Global Cord Blood (NYSE:CO)
- GS ACQUISITION /SH CL A (NYSE:GSAH) and Global Cord Blood (NYSE:CO) are both small-cap unclassified companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk and institutional ownership. Institutional & Insider Ownership 43.7% of GS ACQUISITION /SH CL A […]
- 01/15/2020
|
Liteye Systems Delivers Another $10M in CUAS Solutions!
- Centennial, CO, Jan. 13, 2020 -- Centennial Colorado — Liteye Systems, Inc, a world leader in Counter Unmanned Aerial Systems (CUAS), announced the shipment of an additional.
- 01/13/2020
|
Casino Close To Selling Discount Chain Leader Price To Rival Aldi: Source | ESM Magazine
- French retailer Casino Guichard Perrachon SA is in advanced talks to sell its Leader Price discount chain to German low-cost rival Aldi, a source has revealed. On Satu…
- 01/13/2020
|
Casino Guichard Perrachon : sur le point de céder son enseigne Lidl à Aldi-source | Zone bourse
- Le distributeur français Casino Guichard Perrachon SA est en discussions avancées sur la cession de son enseigne Leader Price au groupe allemand Aldi, a indiqué samedi une source au fait du dossier. … | 11 janvier 2020
- 01/11/2020
|
Casino está próximo de vender rede Leader Price para rival Aldi, diz fonte
- Por Tatiana Bautzer e Dominique VidalonSÃO PAULO/PARIS (Reuters) - O varejista francês Casino Guichard Perrachon SA CASP.PA> está em negociações avançadas para vender a varejista de descontos Leader Price para a rival… Leia mais
- 01/11/2020
|
Infosys audit panel gives clean chit to top leadership
- SEC & Sebi probe still on, Nilekani hints at ‘whistleblower’ being an outsider; co raises FY20 guidance.
- 01/11/2020
|
Danone: Good Company But Not A European Champion
- I am convinced that there are European champions that are largely unknown, but nevertheless promise long-term growth for investors. It is astonishing how little
- 01/10/2020
|
Hotels - A Hidden Source of Carbon Monoxide Poisoning
- Carbon monoxide (CO) poisoning often occurs during foul weather. Keyless ignition systems and hotels are less well-known causes. Here's how to protect yourself.
- 01/09/2020
|
Bharti Airtel rallies 3% as Co launches $2 billion QIP for AGR dues
- The stock has rallied 6 per cent in the past two trading days on the QIP buzz
- 01/09/2020
|
Bitmain’s former co-CEO speaks out against proposed layoffs
- The co-founder and former co-CEO of cryptocurrency mining hardware manufacturer Bitmain has spoken out against the company’s supposed staff layoffs. In a social media post published earlier today, Zhan said he is “firmly opposed” to the potential redundancies, The Block reports. He further described the potential action as “unreasonable.” The open letter was addressed to Bitmain’s employees and went on to discuss Zhan’s take on the company‘s current situation. According to Zhan, it would be “ridiculous” to undertake staff cuts and reduce head count by 50 percent. The former co-CEO certainly pulled no punches as he described the reportedly planned… This story continues at The Next Web
- 01/06/2020
|
Winter hits Future Retail’s business as footfall drops; but, co expects recovery soon
- The footfalls have seen a drop in some markets and prolonged winters have impacted business for the group. However, the Kishore Biyani-founded group expects recovery going ahead and said that the Q4 looks better.
- 12/26/2019
|
Casino Guichard Perrachon : baisse, Jefferies s'inquiète pour les performances | Zone bourse
- Casino baisse mercredi en Bourse après la publication d'une note d'analyse de Jefferies s'inquiétant pour les performances financières du distributeur français, engagé dans un vaste plan de… | 18 décembre 2019
- 12/18/2019
|
CASINO GUICHARD : Les recommandations des analystes : Casino, Rémy Cointreau, Sopra Steria
- Un seul changement de conseil ce mercredi et il concerne une valeuren dehors du Cac 40.
- 12/18/2019
|
Edited Transcript of CO earnings conference call or presentation 27-Nov-19 1:00pm GMT
- Q2 2020 Global Cord Blood Corp Earnings Call
- 12/17/2019
|
Hedge Funds Have Never Been More Bullish On Global Cord Blood Corporation (CO)
- Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips. That outperformance comes with a price, however, as there are occasional periods of higher volatility. The last 12 months is one of those periods, as the Russell 2000 […]
- 12/15/2019
|
Moody’s keeps India GDP growth forecast at 5.6%
- Growth could be hit as demand has cooled with slow employment growth impacting consumption, co expects 6.6% for ’20 and 6.7% in ’21.
- 12/14/2019
|
Jennifer Egbert Presents a 5,000 SF Modern Luxury Estate to the North Boulder Market
- BOULDER, Colo., Dec. 13, 2019 /PRNewswire/ -- Jennifer Egbert of milehimodern in Boulder, CO is thrilled to announce that The Vista Drive Pavilion is being introduced to the Boulder real estate market on November 7, 2019. This remarkable residence, custom-built by MK Construction and…
- 12/13/2019
|
Lululemon COO to leave for luggage maker Away
- Travel lifestyle brand, Away, says Steph Korey, current CEO and CO, will assume role of executive chairman.
- 12/09/2019
|
PRC NHC Issues New Policy on Cord Blood Banks, Implementation Rules To Be Provided
- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today reported that China's National Health Commission ("NHC") recently issued a new policy allowing the relevant Provincial Health Commissions ("PHCs") to approve cord blood bank licenses in 18 pilot Free Trade Zones ("FTZs") in China.
- 12/06/2019
|
PRC NHC Issues New Policy on Cord Blood Banks, Implementation Rules To Be Provided
|
Global Cord Blood Corporation Announces Results of 2019 Annual General Meeting
- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2019 Annual General Meeting, which was held on December 5, 2019, in Hong Kong S.A.R., China.
- 12/05/2019
|
Global Cord Blood Corporation Announces Results of —…–9 Annual General Meeting
|
Global Cord Blood Corporation (CO) CEO Tina Zheng on Q2 2020 Results - Earnings Call Transcript
|
Global Cord Blood Q2 EPS $0.14 Beats $0.13 Estimate, Sales $43.9M Beat $39.36M Estimate
|
Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2020 Financial Results
- Earnings Call Scheduled for 8:00 a.m. ET on November 27, 2019 HONG KONG , Nov. 21, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord ...
- 11/21/2019
|
Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal —…—… ...
|
Global Cord Blood Corp Comments on New Regulation
- HONG KONG, Nov. 20, 2019 /PRNewswire/ -- Global Cord Blood Corporation (CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today commented on a new regulation related to companies in possession of human DNA information relating to the PRC. The Company is still in the process of evaluating the implications of the new regulation on the cord blood banking industry and its business. The Regulation of the People's Republic of China on the Administration of Human Genetic Resources (the "Regulation") has come into effect and the Company recently received an inquiry concerning its impact on the Company.
- 11/20/2019
|
Global Cord Blood Corp Comments on New Regulation
|
Global Cord Blood Corporation Appoints Mr. Jack Chow As an Independent Non-executive Director
- HONG KONG, Nov. 11, 2019 /PRNewswire/ -- Global Cord Blood Corporation (CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced the appointment of a new independent non-executive director to the Board of Directors of the Company (the "Board"). In order to further strengthen GCBC's Board composition and the Company's leadership position in China's evolving cord blood banking industry, the Board is delighted to announce that Mr. Jack Chow will join the Board as a class B independent non-executive director, effective immediately.
- 11/11/2019
|
Global Cord Blood Corporation Appoints Mr. Jack Chow As an Independent Non-executive Director
|
Were Hedge Funds Right About Warming Up To Global Cord Blood Corp (CO)?
- Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due to a low interest rate environment that leads to companies swapping their equity for debt and focusing mostly on short-term performance such as beating the quarterly earnings estimates. In the first […]
- 11/01/2019
|
Agriculture Market Report For Thursday, Oct. 31
|
Global Automotive Occupant Sensing System Market Growth, Trends, Absolute Opportunity and Value ...
|
Global Automotive Sun Visor Market To Reap Excessive Revenues by —…–9-—…—8
|
Automotive Body Sealing System Market Size, Share —…–9, Growth Outlook, Trends, Industry ...
|
The Committee for China Cord Fairness Announces Support From The Two Leading Proxy Advisory Firms for Proposals Seeking Minority Shareholder Protections and Governance Enhancements at Global Cord Blood Corporation
- Both ISS and Glass Lewis Support Conditioning All Business Transactions on Approval by a Majority of the Unaffiliated Shareholders ISS Notes "A number of governance shortcomings have been identified" ...
- 10/16/2019
|
The Committee for China Cord Fairness Announces Support From The Two Leading Proxy Advisory ...
|
Seasonings And Spices Market Value, Production, Volume, Growth Predictions, and Forecast ...
|
Global Cord Blood Files For $100M Mixed Shelf Offering
|
Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 5, 2019
- HONG KONG, Sept. 20, 2019 /PRNewswire/ -- Global Cord Blood Corporation (CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 2019 annual general meeting of shareholders at its Hong Kong office located at 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong, at 9:00 p.m. Hong Kong Time on December 5, 2019 (8:00 a.m. U.S. Eastern Standard Time on December 5, 2019).
- 09/20/2019
|
Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 5, —…–9
|
Edited Transcript of CO earnings conference call or presentation 28-Aug-19 12:00pm GMT
- Q1 2020 Global Cord Blood Corp Earnings Call
- 09/09/2019
|
66 Biggest Movers From Yesterday
|
65 Biggest Movers From Friday
|
